This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cheng, J. Articles by Wu, X.-R. Search for Related Content PubMed PubMed Citation Articles by Cheng, J. Articles by Wu, X.-R.

Overexpression of Epidermal Growth Factor Receptor in Urothelium Elicits Urothelial Hyperplasia and Promotes Bladder Tumor Growth¹

Departments of Urology [J. C., H. H., Z-T. Z., E. S., T-T. S., X-R. W.], Microbiology [X-R. W.], Pathology [A. P.], Dermatology [T-T. S.], and Pharmacology [T-T. S.], Kaplan Comprehensive Cancer Center, New York University School of Medicine, New York, New York 10016, and Veteran Affairs Medical Center New York, New York 10010 [X-R. W.]

Although urothelium is constantly bathed in high concentrations of epidermal growth factor (EGF) and most urothelial carcinomas overexpress EGF receptor (EGFr), relatively little is known about the role of EGFr signaling pathway in urothelial growth and transformation. In the present study, we used the uroplakin II gene promoter to drive the urothelial overexpression of EGFr in transgenic mice. Three transgenic lines were established, all expressing a higher level of the EGFr mRNA and protein in the urothelium than the nontransgenic controls. The overexpressed EGFr was functionally active because it was autophosphorylated, and its downstream mitogen-activated protein kinases were highly activated. Phenotypically, the urinary bladders of all transgenic lines developed simple urothelial hyperplasia that was strongly positive for proliferative cell nuclear antigen and weakly positive for bromodeoxyuridine incorporation. When coexpressed with the activated Ha-ras oncogene in double transgenic mice, EGFr had no apparent tumor-enhancing effects over the urothelial hyperplastic phenotype induced by Ha-ras oncogene. However, when coexpressed with the SV40 large T antigen, EGFr accelerated tumor growth and converted the carcinoma in situ of the SV40T mice into high-grade bladder carcinomas, without triggering tumor invasion. Our studies indicate that urothelial overexpression of EGFr can induce urothelial proliferation but not frank carcinoma formation. Our results also suggest that, whereas EGFr and Ha-ras, both of which act in the same signal transduction cascade, stimulated urothelial hyperplasia, they were not synergistic in urothelial tumorigenesis, and EGFr overexpression can cooperate with p53 and pRB dysfunction (as occurring in SV40T transgenic mice) to promote bladder tumor growth.

This article has been cited by other articles:

				S. Zhuang, G. R. Kinsey, K. Rasbach, and R. G. Schnellmann Heparin-binding epidermal growth factor and Src family kinases in proliferation of renal epithelial cells Am J Physiol Renal Physiol, March 1, 2008; 294(3): F459 - F468. [Abstract] [Full Text] [PDF]

				G. G. Long, V. L. Reynolds, A. Lopez-Martinez, T. E. Ryan, S. L. White, and S. R. Eldridge Urothelial Carcinogenesis in the Urinary Bladder of Rats Treated with Naveglitazar, a {gamma}-dominant PPAR {alpha}/{gamma} Agonist: Lack of Evidence for Urolithiasis as an Inciting Event Toxicol Pathol, February 1, 2008; 36(2): 218 - 231. [Abstract] [Full Text] [PDF]

				E. M. Balestreire and G. Apodaca Apical Epidermal Growth Factor Receptor Signaling: Regulation of Stretch-dependent Exocytosis in Bladder Umbrella Cells Mol. Biol. Cell, April 1, 2007; 18(4): 1312 - 1323. [Abstract] [Full Text] [PDF]

				W. Liu, D. P. Evanoff, X. Chen, and Y. Luo Urinary Bladder Epithelium Antigen Induces CD8+ T Cell Tolerance, Activation, and Autoimmune Response J. Immunol., January 1, 2007; 178(1): 539 - 546. [Abstract] [Full Text] [PDF]

				H. Tsuruta, H. Kishimoto, T. Sasaki, Y. Horie, M. Natsui, Y. Shibata, K. Hamada, N. Yajima, K. Kawahara, M. Sasaki, et al. Hyperplasia and Carcinomas in Pten-Deficient Mice and Reduced PTEN Protein in Human Bladder Cancer Patients. Cancer Res., September 1, 2006; 66(17): 8389 - 8396. [Abstract] [Full Text] [PDF]

				L.-M. Chen, C. Wang, M. Chen, M. R. Marcello, J. Chao, L. Chao, and K. X. Chai Prostasin attenuates inducible nitric oxide synthase expression in lipopolysaccharide-induced urinary bladder inflammation Am J Physiol Renal Physiol, September 1, 2006; 291(3): F567 - F577. [Abstract] [Full Text] [PDF]

				R.A. Crallan, N.T. Georgopoulos, and J. Southgate Experimental models of human bladder carcinogenesis Carcinogenesis, March 1, 2006; 27(3): 374 - 381. [Abstract] [Full Text] [PDF]

				L. Mo, J. Cheng, E. Y.-H. P. Lee, T.-T. Sun, and X.-R. Wu Gene deletion in urothelium by specific expression of Cre recombinase Am J Physiol Renal Physiol, September 1, 2005; 289(3): F562 - F568. [Abstract] [Full Text] [PDF]